Getting an injection at the doctor’s office does not rank highly on many people’s favourites lists, but thanks to 3M scientists’ the day is getting closer when patients may be receiving their prescription medications at home via microscopic needles.
Pharmaceutical and biotechnology companies can now partner with 3M on development and conducting clinical trials using its 3M Hollow Microstructured Transdermal System (hMTS). Patient-friendly and easy to use, 3M hMTS is designed to open new opportunities for pharmaceutical companies and patients. The device’s availability for clinical trials comes after conducting a number of studies and…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
